Randomized, Controlled, Double-Blind, Cross-Over Trial Assessing Treatment Preference for Pazopanib Versus Sunitinib in Patients With Metastatic Renal Cell Carcinoma: PISCES Study - Concepedia

Concepedia

Publication | Open Access

Randomized, Controlled, Double-Blind, Cross-Over Trial Assessing Treatment Preference for Pazopanib Versus Sunitinib in Patients With Metastatic Renal Cell Carcinoma: PISCES Study

DOI Full Paper Access

438

Citations

9

References

2014

Year

Bernard Escudier, Camillo Porta, Petri Bono, Thomas Powles, Tim Eisen, Cora N. Sternberg, Jürgen E. Gschwend, Ugo De Giorgi, Omi Parikh, Robert D. Hawkins,

Journal of Clinical Oncology

Abstract

This innovative cross-over trial demonstrated a significant patient preference for pazopanib over sunitinib, with HRQoL and safety as key influencing factors.

References

	Year	Citations

Page 1